Loading patent…
OwnerHo Yuan-Soon, Lee Wen-Sen +13inventors
InventorsHo Yuan-Soon, Lee Wen-Sen, Tseng How, Chen Chien-Ho, Lin Chien-Huang, Ho Pei-Yin, Chu Jan-Show, Ho Wei-Lu, Chen Rong-Jane, Wang Ying-Jan, Jeng Jiiang-Huei, Lin Shyr-Yi, Liang Yu-Chih, Lin Jen-Kun, Chen Li-Ching
Estimating the term…
The present invention discloses the use of allylamine derivatives, such as terbinafine, in the inhibition of cancer cell growth. Also disclosed is the synergistic efficacy of allylamine derivatives in combination with other chemotherapeutically active agents, such as nocodazole, in the inhibition of cancers.
A method of treating cancer in warm blooded mammals comprising administering to the mammals a therapeutically effective amount of an allylamine derivative in free base form or in pharmaceutically acceptable salt form.
A pharmaceutical composition for treating cancer in warm blooded mammals comprising a therapeutically effective amount of an allylamine derivative and a pharmaceutically acceptable carrier.
A method of treating cancer with inducing an anticancer-protein in warm blooded mammals comprising administering to the mammals a therapeutically effective amount of an allylamine derivative in free base form or in pharmaceutically acceptable salt form.
A pharmaceutical composition for treating cancer with inducing an anticancer-protein in warm blooded mammals comprising a therapeutically effective amount of an allylamine derivative and a pharmaceutically acceptable carrier.
A method of treating cancer with inhibiting a cyclin related protein in warm blooded mammals comprising administering to the mammals a therapeutically effective amount of an allylamine derivative in free base form or in pharmaceutically acceptable salt form.
A pharmaceutical composition for treating cancer with inhibiting a cyclin related protein in warm blooded mammals comprising a therapeutically effective amount of an allylamine derivative and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.